Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer
@article{TLCR87273, author = {Julie Moeller and Michael D. Green and Nithya Ramnath}, title = {Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer}, journal = {Translational Lung Cancer Research}, volume = {13}, number = {6}, year = {2024}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/87273} }